Swedbank AB decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 0.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,110,658 shares of the healthcare conglomerate’s stock after selling 10,348 shares during the quarter. Swedbank AB’s holdings in UnitedHealth Group were worth $300,533,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of UNH. Founders Capital Management LLC grew its stake in shares of UnitedHealth Group by 3.0% during the 4th quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate’s stock valued at $324,000 after buying an additional 29 shares during the period. Kellett Wealth Advisors LLC raised its holdings in shares of UnitedHealth Group by 1.7% in the 4th quarter. Kellett Wealth Advisors LLC now owns 1,746 shares of the healthcare conglomerate’s stock worth $576,000 after purchasing an additional 29 shares during the period. Cooper Financial Group grew its holdings in shares of UnitedHealth Group by 0.7% during the 4th quarter. Cooper Financial Group now owns 4,338 shares of the healthcare conglomerate’s stock worth $1,432,000 after purchasing an additional 30 shares during the period. Successful Portfolios LLC raised its holdings in UnitedHealth Group by 2.6% in the fourth quarter. Successful Portfolios LLC now owns 1,194 shares of the healthcare conglomerate’s stock valued at $411,000 after buying an additional 30 shares during the period. Finally, Bell Investment Advisors Inc lifted its position in UnitedHealth Group by 14.4% during the first quarter. Bell Investment Advisors Inc now owns 246 shares of the healthcare conglomerate’s stock valued at $67,000 after buying an additional 31 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Stock Up 2.1%
UNH traded up $8.86 on Tuesday, reaching $426.85. The company’s stock had a trading volume of 1,462,714 shares, compared to its average volume of 8,582,945. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $430.20. The business’s 50 day moving average is $392.87 and its 200 day moving average is $335.60. The stock has a market cap of $387.64 billion, a price-to-earnings ratio of 32.26, a price-to-earnings-growth ratio of 1.71 and a beta of 0.62.
UnitedHealth Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were given a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is presently 70.09%.
Analysts Set New Price Targets
UNH has been the topic of a number of research reports. Oppenheimer raised their target price on shares of UnitedHealth Group from $385.00 to $405.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Mizuho boosted their price objective on UnitedHealth Group from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, June 23rd. Finally, Robert W. Baird boosted their target price on shares of UnitedHealth Group from $278.00 to $287.00 and gave the stock an “underperform” rating in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $414.75.
Get Our Latest Report on UnitedHealth Group
Insider Activity at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.28% of the company’s stock.
Key Stories Impacting UnitedHealth Group
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: UnitedHealth said an external audit found nearly 97% of diagnoses in its HouseCalls home-health unit were supported by patient medical records, which may help ease concerns around lawmakers’ scrutiny of the business. Reuters article on home-health diagnoses audit
- Positive Sentiment: The company is emphasizing profitability over rapid growth, with improving margins, stronger earnings, and Optum expansion supporting a longer-term turnaround story. Yahoo Finance article on profitability over growth
- Positive Sentiment: UnitedHealth expanded coverage for Guardant Health’s Shield blood test for adults 45 and older, becoming the first major commercial insurer to do so and reinforcing its role in expanding access to new screening tools. Yahoo Finance article on Shield blood test coverage
- Positive Sentiment: HSBC raised its price target on UNH to $380 and maintained a hold rating, signaling improved sentiment even though the new target remains below the current trading range. Benzinga report on HSBC target increase
- Neutral Sentiment: Several market commentaries highlighted UNH’s rebound, momentum profile, and long-term earnings recovery potential, but these pieces were mostly opinion-driven rather than fresh company-specific catalysts. MSN article on long-term momentum
- Neutral Sentiment: Articles comparing UnitedHealth with peers or discussing recent stock weakness provide context, but they do not add a major new fundamental catalyst on their own. Yahoo Finance article on recent stock decline
UnitedHealth Group Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Read More
- Five stocks we like better than UnitedHealth Group
- 3 Quiet AI Revenue Accelerators With Sales Growth Outpacing Peers
- Top 135 Best Locally Owned BBQ Supply Stores in the U.S., According to Survey [2026]
- Silicon Starvation: Amazon Feasts on Legacy GPUs
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
-EGX.png){kind=small}
